Developer docs
API playgroundTry for free, no card

Search company profiles

Bioness Medical

Full company profile

uuid000r7nb

Namestring
Bioness Medical
Legal namestring
Bioness Medical, Inc.
Company typeenum
Private
Founded yearint
2000
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersValencia, United States
HQ citystring
Valencia
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
neurorehabilitation medical devices, functional electrical stimulation, neuromodulation systems, robotic rehabilitation equipment, stroke rehabilitation therapy
Industry4 codes
1Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
CodeHLAHAMAGPrimaryYes
2Digital Rehabilitation & Physical Therapy Therapeutics
CodeHLACANAJPrimaryNo
3Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS)
CodeHSADAIACPrimaryNo
4Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices)
CodeCRACAQAKPrimaryNo
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Medical Equipment and Supplies Manufacturing3391
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists62134
SIC code3 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Neurorehabilitation Medical Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Medical Device Hardware Sales
TypeHardware Sales
Description

Sale of medical rehabilitation devices including FES systems (L300 Go, L360, H200 Wireless), robotic systems (Vector), and software platforms (BITS). Products are sold as durable medical equipment with prescription requirement.

bionessmedical.com
2Accessories and Consumables
TypeHardware Sales
Description

Ongoing sales of accessories, replacement parts, and consumables including electrodes, cuffs, and batteries for device maintenance and continued use.

bionessmedical.com
3Technical Support and Service
TypeProfessional Services
Description

Technical support services including multi-tiered maintenance plans ensuring continuous system use, extended service contracts, and clinical training programs.

bionessmedical.com
4Clinical Training (Bioness Academy)
TypeProfessional Services
Description

Revenue from comprehensive virtual training platform providing self-paced courses, resource libraries, and on-demand webinars for clinicians advancing expertise in neuro rehabilitation.

bionessmedical.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations
Pricing details1 tier
1Quote-based medical device pricing
ModelOtherBilling cadenceOne time/ perpetual license
Notes

No specific pricing published. Products available by prescription with insurance coverage verification support. Extended service contracts available for ongoing maintenance.

bionessmedical.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1BITS FR
Description

BITS Functional Reality - immersive virtual reality rehabilitation system combining virtual environments with rehabilitation exercises

bionessmedical.com
+7 more records
Core offering1 text field

Bioness Medical develops and manufactures prescription-based medical devices for neurorehabilitation, including functional electrical stimulation (FES) systems for foot drop, thigh weakness, and hand impairment; ceiling-mounted robotic body weight support systems; and software/VR-based therapy platforms. Products are sold to and prescribed by clinicians at rehabilitation hospitals, clinics, and therapy centers for use by patients recovering from stroke, traumatic brain injury, multiple sclerosis, and orthopedic conditions. The company also provides clinician training (Bioness Academy) and patient-facing mobile applications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 40% improvement in walking speed with L300 Go
+4 more records
Product overview1 text field

Bioness Medical develops a comprehensive neurorehabilitation platform comprising neuromodulation systems, robotic systems, and software-based therapy programs. The core product portfolio includes functional electrical stimulation (FES) devices for foot drop (L300 Go), thigh weakness (L360), and hand rehabilitation (H200 Wireless); body weight support systems (Vector, Haloplex); upper-extremity exoskeleton (AURA); and therapy software platforms (BITS, BITS Functional Reality). The products are designed to work both independently and together as an integrated rehabilitation ecosystem, supported by clinical training through Bioness Academy and mobile applications. The April 2026 acquisition of the PoNS System expanded capabilities into non-invasive central neuromodulation via tongue stimulation, enabling clinicians to address both peripheral motor activation and central neural network modulation within a unified rehabilitation approach.

Product and service8 records
1L300 Go System
CategoryFunctional Electrical Stimulation Devices
Description

A functional electrical stimulation (FES) system prescribed by clinicians that provides ankle dorsiflexion for foot drop and knee flexion/extension for thigh weakness. Uses proprietary 3D motion detection with adaptive learning algorithm to detect gait events and deliver stimulation across varying walking speeds, stairs, ramps, and uneven terrain. Indicated for users with foot drop and thigh weakness from stroke, traumatic brain injury, multiple sclerosis, cerebral palsy, and incomplete spinal cord injury.

2L360 Thigh System
CategoryFunctional Electrical Stimulation Devices
Description

A neuromuscular electrical stimulation (NMES) and functional electrical stimulation (FES) device that assists knee flexion or extension for muscle weakness. Uses 3D motion detection to deploy stimulation in three modes: FES gait, cycle training, and NMES training. Indicated for post-surgical quadriceps/hamstring weakness, muscle atrophy prevention, and knee instability after total knee replacement or ACL reconstruction.

3H200 Wireless Hand Rehabilitation System
CategoryFunctional Electrical Stimulation Devices
Description

A wireless functional electrical stimulation system for hand rehabilitation that supports the wrist in a functioning position while stimulating nerves and muscles in the forearm and hand to improve hand function. Indicated for stroke survivors, traumatic brain injury patients, and others with impaired reaching, grasping, pinching, and opening/closing of the hand.

4Vector Gait and Safety System
CategoryRobotic Rehabilitation Equipment
Description

A ceiling-mounted robotic body weight support system that provides dynamic body weight support (DBWS) to minimize fall risk for rehabilitation patients. Features 500 lbs patient weight capacity, active body control fall protection, up to 200 lbs body weight support, and movement detection mirroring patient movement 1000 times per second for immediate responsiveness. Used in clinical rehabilitation settings for gait and overground training.

5BITS (Bioness Integrated Therapy System)
CategoryRehabilitation Therapy Software
Description

A software-based therapy platform for rehabilitation facilities that challenges, assesses, and tracks a patient's deficiencies in vision, cognition, motor, and balance through an interactive touchscreen display. Offers over 60 multidisciplinary programs designed to improve clinical utility, patient engagement, and clinician efficiency.

6BITS Functional Reality (BITS FR)
CategoryImmersive Rehabilitation Therapy Systems
Description

An immersive virtual reality, mixed reality, and functional reality rehabilitation system that works with Head-Mounted Displays (HMDs) to provide virtual environments for upper-extremity rehabilitation exercises. Supports occupational therapy, physical therapy, and speech therapy through interactive exercises in everyday simulated environments. Launched October 2025.

7PoNS (Portable Neuromodulation Stimulator) System
CategoryNeuromodulation Devices
Description

A non-invasive central neuromodulation device that delivers stimulation via the tongue to modulate central neural networks. Acquired from Helius Medical Technologies in April 2026 and added to Bioness's portfolio to complement its peripheral functional electrical stimulation platform with a dual-front neuromodulation approach for treating complex neurological conditions.

8Bioness Academy
CategoryClinical Education and Training Services
Description

A comprehensive virtual training platform that supports clinicians in advancing their expertise in neurorehabilitation. Offers self-paced web-based courses, a resource library with product-specific guides and best practice materials, and on-demand webinars led by expert faculty for clinicians seeking continuing education.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-09
Description

Bioness Medical acquired the Portable Neuromodulation Stimulator (PoNS) System product line from Helius Medical Technologies. The acquisition combines Bioness's peripheral functional electrical stimulation platform with PoNS's central brain stimulation technology via tongue, creating a dual-front neuromodulation approach for treating complex neurological conditions.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Peers10 records
TypeEmerging player
Description

MindMaze builds digital neurotherapeutics and VR/MR platforms for neurological recovery and assessment. Comparable as a competitor in the immersive VR/MR rehabilitation space where Bioness has launched BITS Functional Reality.

TypeEmerging player
Description

ReWalk Robotics develops wearable robotic exoskeletons for individuals with spinal cord injury and other mobility impairments. Comparable as a focused exoskeleton competitor targeting overlapping neurological rehabilitation indications.

TypeDirect peer
Description

Tyromotion develops robotic and sensor-based rehabilitation devices for upper and lower extremities used in clinical therapy. Comparable because it competes with Bioness's Vector, AURA, and H200 in the robotic and FES-assisted rehabilitation market.

TypeDirect peer
Description

Saebo is a direct competitor in the upper-extremity and hand rehabilitation device space, offering functional orthoses and electrical stimulation products for stroke and neurological recovery. Comparable because both companies sell clinical FES/orthotic devices to rehabilitation facilities and home users.

TypeDirect peer
Description

AlterG manufactures anti-gravity treadmills using differential air pressure for body weight support during rehab. Comparable because AlterG directly competes with Bioness's Vector system in body weight-supported gait training for neurological and orthopedic patients.

TypeDirect peer
Description

Ekso Bionics builds wearable robotic exoskeletons for medical and industrial use, including the EksoNR for stroke and brain injury rehabilitation. Directly comparable as a developer of exoskeleton and robotic rehab devices targeting similar neurological patient populations.

TypeDirect peer
Description

Hocoma develops robotic and sensor-based devices for rehabilitation, including the Lokomat and Armeo product lines. Comparable because Hocoma directly competes with Bioness's Vector (gait/body weight support) and AURA (upper-extremity exoskeleton) products in the same clinical rehab channels.

TypeBroad incumbent
Description

Ottobock is a global leader in prosthetics, orthotics, and rehabilitation technology with a broad medical device portfolio. Comparable as a much larger incumbent operating in the same orthopedic and rehabilitation space, including FES-adjacent orthotic products for mobility-impaired patients.

TypeOthers
Description

Helius Medical Technologies developed the PoNS (Portable Neuromodulation Stimulator) System, which Bioness acquired in April 2026. Relevant as a related party and former product originator whose technology now sits inside Bioness's platform.

TypeDirect peer
Description

Restorative Therapies makes FES-based cycling and therapy systems (RT300, Xcite) for neurological rehabilitation in clinical and home settings. Comparable as a direct FES device competitor serving similar stroke, MS, and spinal cord injury patient populations.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bioness Medical

Neurorehabilitation Medical Devicesbionessmedical.com

Bioness Medical firmographics

Firmographics
Name
Bioness Medical
Legal name
Bioness Medical, Inc.
Website
https://bionessmedical.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
251–500 employees
Ownership category
akta.pro rank

Bioness Medical industry classification

Industry
Product category
Neurorehabilitation Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)
akta.pro secondary industries
Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ), Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC), Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices) (CRACAQAK)

Keywords

  • Neurorehabilitation medical devices
  • Functional electrical stimulation
  • Neuromodulation systems
  • Robotic rehabilitation equipment
  • Stroke rehabilitation therapy

Where Bioness Medical is headquartered

Location

Headquarters

HQ city
Valencia
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Bioness Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations

Revenue model

  1. Medical Device Hardware Sales: Sale of medical rehabilitation devices including FES systems (L300 Go, L360, H200 Wireless), robotic systems (Vector), and software platforms (BITS). Products are sold as durable medical equipment with prescription requirement.
  2. Accessories and Consumables: Ongoing sales of accessories, replacement parts, and consumables including electrodes, cuffs, and batteries for device maintenance and continued use.
  3. Technical Support and Service: Technical support services including multi-tiered maintenance plans ensuring continuous system use, extended service contracts, and clinical training programs.
  4. Clinical Training (Bioness Academy): Revenue from comprehensive virtual training platform providing self-paced courses, resource libraries, and on-demand webinars for clinicians advancing expertise in neuro rehabilitation.

Pricing tiers

ModelBillingPrice
OtherOne time/ perpetual licenseQuote-based medical device pricing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Bioness Medical product offering

Product offering

Core offering

Bioness Medical develops and manufactures prescription-based medical devices for neurorehabilitation, including functional electrical stimulation (FES) systems for foot drop, thigh weakness, and hand impairment; ceiling-mounted robotic body weight support systems; and software/VR-based therapy platforms. Products are sold to and prescribed by clinicians at rehabilitation hospitals, clinics, and therapy centers for use by patients recovering from stroke, traumatic brain injury, multiple sclerosis, and orthopedic conditions. The company also provides clinician training (Bioness Academy) and patient-facing mobile applications.

Product overview

Bioness Medical develops a comprehensive neurorehabilitation platform comprising neuromodulation systems, robotic systems, and software-based therapy programs. The core product portfolio includes functional electrical stimulation (FES) devices for foot drop (L300 Go), thigh weakness (L360), and hand rehabilitation (H200 Wireless); body weight support systems (Vector, Haloplex); upper-extremity exoskeleton (AURA); and therapy software platforms (BITS, BITS Functional Reality). The products are designed to work both independently and together as an integrated rehabilitation ecosystem, supported by clinical training through Bioness Academy and mobile applications. The April 2026 acquisition of the PoNS System expanded capabilities into non-invasive central neuromodulation via tongue stimulation, enabling clinicians to address both peripheral motor activation and central neural network modulation within a unified rehabilitation approach.

Differentiator

Problem solved

Functional benefit

Brands

  • BITS FR: BITS Functional Reality - immersive virtual reality rehabilitation system combining virtual environments with rehabilitation exercises
  • L300 Go
  • L360
  • H200 Wireless
  • Vector
  • BITS
  • AURA
  • Haloplex

Products and services

  • L300 Go System A functional electrical stimulation (FES) system prescribed by clinicians that provides ankle dorsiflexion for foot drop and knee flexion/extension for thigh weakness. Uses proprietary 3D motion detection with adaptive learning algorithm to detect gait events and deliver stimulation across varying walking speeds, stairs, ramps, and uneven terrain. Indicated for users with foot drop and thigh weakness from stroke, traumatic brain injury, multiple sclerosis, cerebral palsy, and incomplete spinal cord injury.
  • L360 Thigh System A neuromuscular electrical stimulation (NMES) and functional electrical stimulation (FES) device that assists knee flexion or extension for muscle weakness. Uses 3D motion detection to deploy stimulation in three modes: FES gait, cycle training, and NMES training. Indicated for post-surgical quadriceps/hamstring weakness, muscle atrophy prevention, and knee instability after total knee replacement or ACL reconstruction.
  • H200 Wireless Hand Rehabilitation System A wireless functional electrical stimulation system for hand rehabilitation that supports the wrist in a functioning position while stimulating nerves and muscles in the forearm and hand to improve hand function. Indicated for stroke survivors, traumatic brain injury patients, and others with impaired reaching, grasping, pinching, and opening/closing of the hand.
  • Vector Gait and Safety System A ceiling-mounted robotic body weight support system that provides dynamic body weight support (DBWS) to minimize fall risk for rehabilitation patients. Features 500 lbs patient weight capacity, active body control fall protection, up to 200 lbs body weight support, and movement detection mirroring patient movement 1000 times per second for immediate responsiveness. Used in clinical rehabilitation settings for gait and overground training.
  • BITS (Bioness Integrated Therapy System) A software-based therapy platform for rehabilitation facilities that challenges, assesses, and tracks a patient's deficiencies in vision, cognition, motor, and balance through an interactive touchscreen display. Offers over 60 multidisciplinary programs designed to improve clinical utility, patient engagement, and clinician efficiency.
  • BITS Functional Reality (BITS FR) An immersive virtual reality, mixed reality, and functional reality rehabilitation system that works with Head-Mounted Displays (HMDs) to provide virtual environments for upper-extremity rehabilitation exercises. Supports occupational therapy, physical therapy, and speech therapy through interactive exercises in everyday simulated environments. Launched October 2025.
  • PoNS (Portable Neuromodulation Stimulator) System A non-invasive central neuromodulation device that delivers stimulation via the tongue to modulate central neural networks. Acquired from Helius Medical Technologies in April 2026 and added to Bioness's portfolio to complement its peripheral functional electrical stimulation platform with a dual-front neuromodulation approach for treating complex neurological conditions.
  • Bioness Academy A comprehensive virtual training platform that supports clinicians in advancing their expertise in neurorehabilitation. Offers self-paced web-based courses, a resource library with product-specific guides and best practice materials, and on-demand webinars led by expert faculty for clinicians seeking continuing education.

Quantifiable outcome

  • 40% improvement in walking speed with L300 Go
  • +4 more outcomes

Companies that use Bioness Medical

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles2 records

Bioness Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature9 records

Bioness Medical partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Helius Medical TechnologiescoreStrategic or Co-development Partner · 9 April 2026Bioness Medical acquired the Portable Neuromodulation Stimulator (PoNS) System product line from Helius Medical Technologies. The acquisition combines Bioness's peripheral functional electrical stimulation platform with PoNS's central brain stimulation technology via tongue, creating a dual-front neuromodulation approach for treating complex neurological conditions.

Scale indicators11 records

Recent moves6 records

Bioness Medical competitors and assessment

Company assessment

Emerging players

  • MindMaze: MindMaze builds digital neurotherapeutics and VR/MR platforms for neurological recovery and assessment. Comparable as a competitor in the immersive VR/MR rehabilitation space where Bioness has launched BITS Functional Reality.
  • ReWalk Robotics: ReWalk Robotics develops wearable robotic exoskeletons for individuals with spinal cord injury and other mobility impairments. Comparable as a focused exoskeleton competitor targeting overlapping neurological rehabilitation indications.

Direct peers

  • Tyromotion: Tyromotion develops robotic and sensor-based rehabilitation devices for upper and lower extremities used in clinical therapy. Comparable because it competes with Bioness's Vector, AURA, and H200 in the robotic and FES-assisted rehabilitation market.
  • Saebo: Saebo is a direct competitor in the upper-extremity and hand rehabilitation device space, offering functional orthoses and electrical stimulation products for stroke and neurological recovery. Comparable because both companies sell clinical FES/orthotic devices to rehabilitation facilities and home users.
  • AlterG: AlterG manufactures anti-gravity treadmills using differential air pressure for body weight support during rehab. Comparable because AlterG directly competes with Bioness's Vector system in body weight-supported gait training for neurological and orthopedic patients.
  • Ekso Bionics: Ekso Bionics builds wearable robotic exoskeletons for medical and industrial use, including the EksoNR for stroke and brain injury rehabilitation. Directly comparable as a developer of exoskeleton and robotic rehab devices targeting similar neurological patient populations.
  • Hocoma (part of DIH): Hocoma develops robotic and sensor-based devices for rehabilitation, including the Lokomat and Armeo product lines. Comparable because Hocoma directly competes with Bioness's Vector (gait/body weight support) and AURA (upper-extremity exoskeleton) products in the same clinical rehab channels.
  • Restorative Therapies: Restorative Therapies makes FES-based cycling and therapy systems (RT300, Xcite) for neurological rehabilitation in clinical and home settings. Comparable as a direct FES device competitor serving similar stroke, MS, and spinal cord injury patient populations.

Broad incumbents

  • Ottobock: Ottobock is a global leader in prosthetics, orthotics, and rehabilitation technology with a broad medical device portfolio. Comparable as a much larger incumbent operating in the same orthopedic and rehabilitation space, including FES-adjacent orthotic products for mobility-impaired patients.

Others

  • Helius Medical Technologies: Helius Medical Technologies developed the PoNS (Portable Neuromodulation Stimulator) System, which Bioness acquired in April 2026. Relevant as a related party and former product originator whose technology now sits inside Bioness's platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Bioness Medical social profiles

Digital presence

Bioness Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bioness Medical leadership team

Management profile

Number of profiles

Profiles1 record

Bioness Medical subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Bioness Medical funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bioness Medical M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioness Medical

What does Bioness Medical do?

Bioness Medical develops and manufactures prescription-based medical devices for neurorehabilitation, including functional electrical stimulation (FES) systems for foot drop, thigh weakness, and hand impairment; ceiling-mounted robotic body weight support systems; and software/VR-based therapy platforms. Products are sold to and prescribed by clinicians at rehabilitation hospitals, clinics, and therapy centers for use by patients recovering from stroke, traumatic brain injury, multiple sclerosis, and orthopedic conditions. The company also provides clinician training (Bioness Academy) and patient-facing mobile applications.

Is Bioness Medical a public or private company?

Bioness Medical is a private company. It is classified as private equity controlled and is currently operating.

When was Bioness Medical founded?

Bioness Medical was founded in 2000. It employs 251 to 500 people.

Where is Bioness Medical based?

Bioness Medical is headquartered in Valencia, United States, in the North America region.

How does Bioness Medical make money?

Four revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are accessories and Consumables, technical Support and Service and clinical Training (Bioness Academy).

Who are Bioness Medical's main competitors?

Emerging players on record are MindMaze and ReWalk Robotics. Direct peers are Tyromotion, Saebo, AlterG, Ekso Bionics, Hocoma (part of DIH) and Restorative Therapies. Ottobock is listed as a broad incumbent. Helius Medical Technologies is listed as an others.

Does Bioness Medical have an API?

No public API is recorded for Bioness Medical.

What industry is Bioness Medical in?

Bioness Medical's product category is Neurorehabilitation Medical Devices. Its primary akta.pro industry code is HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices), with a secondary code of HLACANAJ, Digital Rehabilitation & Physical Therapy Therapeutics. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0Horizon Technology Finance Provides $15 Million Loan Facility To Bioness MedicalHorizon Technology Finance provided Bioness Medical with a $15 million senior credit facility, including $10 million funded at closing and up to $5 million more. Bioness will use the capital to invest in innovation, expand its product portfolio, and support growth.FinSMEsBioness Medical Receives $15M Credit FacilityBioness Medical, a Valencia, CA-based neurorehabilitation technology provider, received a $15M credit facility led by Horizon Technology Finance Corporation. The company will use the funds to invest in innovation, expand its product portfolio, and support growth. The company serves patients and healthcare providers globally.citybizHorizon Technology Finance Provides $15 Million Credit Facility to Bioness MedicalHorizon Technology Finance provided a $15 million senior credit facility to Bioness Medical, a neurorehabilitation technology developer. The financing includes $10 million funded at closing and $5 million available for growth. Bioness develops FDA-approved technologies for stroke and spinal cord injury recovery.openPR.comNeuromodulation Devices Industry Set to Strategic Investment by United States & JapanDataM Intelligence published its Neuromodulation Devices Market report, valued at US$111.56 billion in 2025 and projected to reach US$203.45 billion by 2033, growing at a 7.0% CAGR from 2026 to 2033. The report highlights strategic investments from the United States and Japan, FDA approvals for Saluda Medical's CAP24 paddle lead and Bioness Medical's PoNS system, and notable M&A activity including Medtronic's acquisition of SPR Therapeutics and Boston Scientific's acquisitions of Nalu Medical and Valencia Technologies. Key players including Medtronic, Boston Scientific, Abbott, Nevro Corp., and Inspire Medical Systems are driving growth through AI-enabled stimulation technologies, remote monitoring capabilities, and portfolio expansion across chronic pain, urology, and neurological applications.Medical Device NetworkFDA clears Bioness Medical’s neuromodulation system for stroke rehabilitationThe FDA has cleared Bioness Medical's PoNS oral neuromodulation system for rehabilitating stroke patients with gait deficits. The device, which stimulates cranial nerves through a mouthpiece placed on the tongue, demonstrated statistically significant improvements in walking function in a 159-patient clinical trial, with treated patients showing a 45.5% greater response rate compared to physical therapy alone. Bioness acquired the PoNS product line from Solana Company (formerly Helius Medical Technologies) in April 2026, expanding the device's indication from multiple sclerosis treatment to stroke rehabilitation.PR NewswireBioness Medical Announces 510(k) Clearance for PoNS® (Portable Neuromodulation Stimulator) to Manage Patients Recovering from StrokeBioness Medical announced FDA 510(k) clearance for its PoNS® (Portable Neuromodulation Stimulator) System to treat dynamic gait deficit due to chronic stroke symptoms, making it the first non-invasive, orally applied neuromodulation device cleared for stroke rehabilitation in the US. The clearance was supported by a three-study registrational program involving 159 patients at 10 centers in the US and Canada, which demonstrated a statistically significant 45.5% increased response rate compared to physical therapy alone, with a favorable safety profile and no treatment-related serious adverse events. The company highlighted that with existing Medicare coverage, PoNS will be accessible and affordable for the more than 7 million Americans living with stroke-related gait disability.MorningstarBioness Medical Announces 510(k) Clearance for PoNS® (Portable Neuromodulation Stimulator) to Manage Patients Recovering from StrokeBioness Medical received FDA 510(k) clearance for its PoNS neuromodulation device to treat dynamic gait deficit from chronic stroke. The clearance is based on a three-study, 159-patient program showing a 45.5% higher response rate versus physical therapy alone. The device expands the company's FES platform for home use.PR NewswireBioness Medical Welcomes Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical OfficerBioness Medical announced the appointment of Dr. Antonella Favit-Van Pelt as its new Chief Medical Officer, effective June 25, 2026. Dr. Favit-Van Pelt brings over 20 years of experience as a board-certified neurologist with a Ph.D. in Pharmacology, transitioning from her role as CMO at Helius Medical Inc., where she led the PoNS device's 510(k) submission and secured Medicare coverage. At Bioness, she will focus on strategic development initiatives, regulatory efforts, and expanding payer access to the company's rehabilitation technologies.Pulse 2.0Bioness Medical Acquires PoNS Neuromodulation System To Expand Neurorehabilitation PlatformBioness Medical has acquired the PoNS (Portable Neuromodulation Stimulator) System product line, expanding its neurorehabilitation platform from peripheral functional electrical stimulation into non-invasive central neuromodulation. The PoNS technology delivers stimulation through the tongue to activate cranial nerve pathways for improving gait and balance in patients with neurological conditions. This acquisition marks Bioness Medical's third strategic acquisition since becoming an independent neurorehabilitation company following its purchase by Accelmed Partners in December 2024.PR NewswireBioness Medical Acquires the Portable Neuromodulation Stimulator (PoNS®) SystemBioness Medical announced the acquisition of the PoNS (Portable Neuromodulation Stimulator) System product line, expanding its capabilities into non-invasive central neuromodulation delivered via tongue stimulation. The acquisition complements Bioness's existing functional electrical stimulation portfolio, enabling clinicians to address both peripheral motor activation and central neural network modulation within a unified rehabilitation approach. This move represents Bioness Medical's third acquisition since becoming an independent company following its acquisition by Accelmed Partners in December 2024.